Yuka Miyamoto

Dr. Yuka Miyamoto

Oral Pathology, Asahi University, Gifu City, Japan
orcid
Assistant Professor

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MHMikito Hayakawa
Mikito Hayakawa
TMTakashi Moritake
Takashi Moritake
FKFumikatsu Kataoka
Fumikatsu Kataoka
TTTomoji Takigawa
Tomoji Takigawa
YKYasuhiro Koguchi
Yasuhiro Koguchi
YMYuji Matsumaru
Yuji Matsumaru

1 December 2011 in Radiation Measurements
Verified
Journal Article
Closed access
TMTakashi Moritake
Takashi Moritake
MHMikito Hayakawa
Mikito Hayakawa
YMYuji Matsumaru
Yuji Matsumaru
TTTomoji Takigawa
Tomoji Takigawa
YKYasuhiro Koguchi
Yasuhiro Koguchi
HSHidehiko Sakurai
Hidehiko Sakurai

18 August 2021 in Materials
Verified
Journal Article
Open access
PDF file
MYMaiko Yamada
Maiko Yamada
MNMotohiko Nagayama
Motohiko Nagayama
Yuka MiyamotoYuka Miyamoto
Yuka Miyamoto
SKSatoshi Kawano
Satoshi Kawano
YTYoshiaki Takitani
Yoshiaki Takitani
TYTakakazu Yoshida
Takakazu Yoshida
Mineral trioxide aggregate (MTA) is an alternative endodontic material that predicts conductive or inductive calcified tissue formation from immature pulp mesenchymal stem cells (IPMSCs). The purpose of this study was to investigate whether MTA could promote reparative odontoblast differentiation via IPMSCs in the early phase of regeneration and compare with calcium hydroxide (CH). Direct pulp capping using calcium hydroxide (CH), MTA, and MTA with platelet-rich plasma (MTA + PRP) was performed on maxillary first molars of 8-week-old male Wistar rats (n = 36). After 3, 7, or 14 days, the teeth were analyzed for mineral density (MD) and volume of MD (VMD) via micro-focusing computed tomography (µCT), nestin, dentin matrix acidic phosphoprotein 1 (DMP1) immunohistochemistry, and real-time PCR for DMP1 mRNA expression. MTA stimulated the early phase differentiation of the IPMSCs into odontoblasts, with positive results for nestin and DMP1 compared with CH. Moreover, MTA + PRP stimulated calcified granule and dentin bridge formation through calcium mineral deposition, following the induction of DMP1 mRNA expression in IPMSCs. Our results suggested that the combination of MTA and PRP is an effective and clinically applicable method for activating endogenous dental pulp stem cells into odontoblasts in the early stages of pulp regeneration.

1 September 2020 in Radiation Measurements
Verified
Journal Article
Closed access
FDF. D’eRrico
F. D’eRrico
LALuis Abegão
Luis Abegão
SSS.O. Souza
S.O. Souza
ACAndrea Chierici
Andrea Chierici
LLL. Lazzeri
L. Lazzeri
TYT. Yamamoto
T. Yamamoto

10 September 2024 in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
Verified
Journal Article
Closed access
Yuka MiyamotoYuka Miyamoto
Yuka Miyamoto
KKKazuki Kiho
Kazuki Kiho
DYDaisuke Yokokawa
Daisuke Yokokawa
THTomoya Hasegawa
Tomoya Hasegawa
CSChinami Sakai
Chinami Sakai
MNMotohiko Nagayama
Motohiko Nagayama

11 March 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
Yuka MiyamotoYuka Miyamoto
Yuka Miyamoto
YKYuka Kato
Yuka Kato
RNRyan Needle
Ryan Needle
JKJulie Yongsook Kim
Julie Yongsook Kim
JKJin Koo Kim
Jin Koo Kim
Insoon ChangInsoon Chang
Insoon Chang
Background/Objectives: Endodontic sealers can interact with periapical tissues through extrusion, yet the molecular mechanisms underlying their biological effects remain poorly defined. This study investigated how commonly used sealers influence mitogen-activated protein kinase (MAPK) signaling, cell viability, and osteogenic-associated responses in MC3T3-E1 pre-osteoblasts. Methods: Four commercial sealers, Calcium-silicate-based Bioceramic Sealer (EndoSequence® BC Sealer, BC), Zinc oxide eugenol sealer (Kerr Pulp Canal Sealer, ZOE), Sealapex™, and AH26®, were applied as standardized pellets, allowed to set, and cultured with MC3T3-E1 cells. Calcium deposition was assessed by Alizarin Red S (ARS) staining, and MAPK activation was evaluated by Western blotting. Due to excessive solubility (Sealapex™) or poor cell survival (AH26®), mechanistic analyses were performed only for BC and ZOE. Osteogenic-associated gene expression was measured by qRT-PCR, and the functional role of MAPK signaling was assessed using ERK, JNK, and p38 inhibitors. Results: BC and Sealapex™ produced robust ARS staining, while ZOE and AH26® produced minimal mineral-associated staining. Both BC and ZOE activated ERK, JNK, and p38, with ZOE inducing higher phosphorylation. However, BC maintained greater cell viability and increased Runx2 and Osx expression, whereas ZOE impaired early cell attachment and viability. MAPK inhibition in BC-treated cultures reduced osteogenic-associated gene expression and ARS staining, indicating MAPK involvement in BC-mediated responses. Conclusions: BC and ZOE elicit distinct MAPK activation patterns and cellular responses. Under the conditions tested, BC promoted a more favorable osteogenic-associated response, whereas ZOE compromised early cell viability. These mechanistic insights may help explain clinical differences in periapical tissue responses to sealer extrusion.